Education
About Us
Working with TipRanks
Follow Us
Klotho Neurosciences (KLTO)
NASDAQ:KLTO
Total Valuation
Klotho Neurosciences has a market cap or net worth of $26.40M. The enterprise value is ―.
Market Cap$26.40M
Enterprise Value―
Share Statistics
Klotho Neurosciences has 72,536,720 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding72,536,720
Owned by Insiders9.80%
Owned by Institutions0.01%
Financial Efficiency
Klotho Neurosciences’s return on equity (ROE) is -5.19 and return on invested capital (ROIC) is -373.94%.
Return on Equity (ROE)-5.19
Return on Assets (ROA)-2.50
Return on Invested Capital (ROIC)-373.94%
Return on Capital Employed (ROCE)-4.58
Revenue Per Employee0.00
Profits Per Employee-2.05M
Employee Count3
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Klotho Neurosciences is ―. Klotho Neurosciences’s PEG ratio is -0.00003.
PE Ratio―
PS Ratio0.00
PB Ratio7.88
Price to Fair Value7.88
Price to FCF-3.04
Price to Operating Cash Flow-5.28
PEG Ratio-0.00003
Income Statement
In the last 12 months, Klotho Neurosciences had revenue of 0.00 and earned -6.15M in profits. Earnings per share was -0.32.
Revenue0.00
Gross Profit0.00
Operating Income-5.54M
Pretax Income-6.15M
Net Income-6.15M
EBITDA-5.79M
Earnings Per Share (EPS)-0.32
Cash Flow
In the last 12 months, operating cash flow was -5.55M and capital expenditures 5.00, giving a free cash flow of -5.55M billion.
Operating Cash Flow-5.55M
Free Cash Flow-5.55M
Free Cash Flow per Share-0.08
Dividends & Yields
Klotho Neurosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.65
52-Week Price Change-21.74%
50-Day Moving Average0.48
200-Day Moving Average0.60
Relative Strength Index (RSI)37.42
Average Volume (3m)876.92K
Important Dates
Klotho Neurosciences upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Klotho Neurosciences as a current ratio of 0.13, with Debt / Equity ratio of 0.00%
Current Ratio0.13
Quick Ratio0.13
Debt to Market Cap0.03
Net Debt to EBITDA-0.04
Interest Coverage Ratio-15.54
Taxes
In the past 12 months, Klotho Neurosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Klotho Neurosciences EV to EBITDA ratio is -1.65, with an EV/FCF ratio of -3.11.
EV to Sales0.00
EV to EBITDA-1.65
EV to Free Cash Flow-3.11
EV to Operating Cash Flow-3.24
Balance Sheet
Klotho Neurosciences has $7.35M in cash and marketable securities with $0.00 in debt, giving a net cash position of $7.35M billion.
Cash & Marketable Securities$7.35M
Total Debt$0.00
Net Cash$7.35M
Net Cash Per Share$0.10
Tangible Book Value Per Share-$0.06
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Klotho Neurosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―